Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS
about
Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorderA review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Delayed amnesic syndrome after riluzole use in major depressive disorder: a case report.Riluzole Serum Concentration in Pediatric Patients Treated for Obsessive-Compulsive Disorder.Discovery of Tirasemtiv, the First Direct Fast Skeletal Muscle Troponin Activator.
P2860
Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2007
@uk
name
Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS
@en
Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS
@nl
type
label
Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS
@en
Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS
@nl
prefLabel
Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS
@en
Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS
@nl
P2093
P2860
P1476
Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS
@en
P2093
Humaira Khan
Jennifer Armstrong
Nailah Siddique
Robert Sufit
Scott Heller
Senda Ajroud-Driss
Teepu Siddique
Thomas J Lukas
P2860
P304
P356
10.1080/17482960701500650
P577
2007-10-01T00:00:00Z